A REVIEW OF PHARMACOECONOMIC EVALUATIONS OF NEW AND EXISTING TECHNOLOGIES BY THE NATIONAL CENTRE FOR PHARMACOECONOMICS IN IRELAND

被引：0
|
作者：
Tilson, L. [1 ]
O'Leary, A. [1 ]
Usher, C. [1 ]
Barry, M. [1 ]
机构：
[1] Natl Ctr Pharmacoecon, Dublin, Ireland
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74224-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A250 / A250
页数：1
相关论文
共 20 条
  • [1] SURVIVAL ANALYSIS USED IN COMPANY SUBMISSIONS TO THE NATIONAL CENTRE FOR PHARMACOECONOMICS, IRELAND
    McCullagh, L.
    Barry, M.
    VALUE IN HEALTH, 2013, 16 (07) : A398 - A398
  • [2] DEVELOPMENT OF THE PATIENT ORGANISATION SUBMISSION PROCESS IN THE NATIONAL CENTRE FOR PHARMACOECONOMICS (NCPE), IRELAND
    Hanevy, A.
    Gorry, C.
    Tilson, L.
    O'Leary, A.
    Barry, M.
    VALUE IN HEALTH, 2018, 21 : S151 - S151
  • [3] A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland
    Felicity Lamrock
    Laura McCullagh
    Lesley Tilson
    Michael Barry
    The European Journal of Health Economics, 2020, 21 : 895 - 901
  • [4] A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland
    Lamrock, Felicity
    McCullagh, Laura
    Tilson, Lesley
    Barry, Michael
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (06): : 895 - 901
  • [5] SURVEY OF THE PATIENT ORGANISATION SUBMISSION PROCESS (POSP) TO THE NATIONAL CENTRE FOR PHARMACOECONOMICS (NCPE) IN IRELAND
    Gorry, C.
    Hanevy, A.
    O'Leary, A.
    Tilson, L.
    Barry, M.
    VALUE IN HEALTH, 2018, 21 : S151 - S151
  • [6] Precision Versus Non-Precision Oncology Drug Submissions to the National Centre for Pharmacoeconomics in Ireland
    Agh, T.
    Hiligsmann, M.
    Jakab, I
    Beaudart, C.
    Manias, E.
    Borah, B.
    Pednekar, P.
    Zeber, J.
    Turcu-Stiolica, A.
    Daly, C.
    Shah, C.
    Atal, S.
    Sharma, M.
    Zhao, Y.
    Dimitrova, M.
    Kamat, S.
    Milky, G.
    Hutchinson, D.
    Gangan, N.
    Unni, E.
    Brzozowska, M.
    Hajimiri, S. H.
    Janodia, M.
    Peterson, A.
    VALUE IN HEALTH, 2022, 25 (12) : S334 - S334
  • [7] DEVELOPMENT OF PLAIN ENGLISH SUMMARIES OF HEALTH TECHNOLOGY ASSESSMENT (HTA) REPORTS IN THE NATIONAL CENTRE FOR PHARMACOECONOMICS (NCPE) IRELAND
    Gorry, C.
    Hanevy, A.
    Tilson, L.
    Barry, M.
    VALUE IN HEALTH, 2019, 22 : S823 - S823
  • [8] EXAMINING THE CONSISTENCY AND ACCURACY OF THE BUDGET IMPACT MODELS SUBMITTED TO THE NATIONAL CENTRE FOR PHARMACOECONOMICS IN IRELAND TO AID THE CREATION OF AN APPLICANT TEMPLATE
    Lamrock, F.
    Tilson, L.
    McCullagh, L.
    Barry, M.
    VALUE IN HEALTH, 2018, 21 : S312 - S312
  • [9] Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic review
    He, Zixuan
    Huang, Xianqin
    Chen, Dingyi
    Wang, Guoan
    Zhu, Yuezhen
    Li, Huangqianyu
    Han, Sheng
    Shi, Luwen
    Guan, Xiaodong
    BMJ GLOBAL HEALTH, 2023, 8 (11):
  • [10] New Generation of Fluconazole: A Review on Existing Researches and Technologies
    Behtash, Afsaneh
    Nafisi, Shohreh
    Maibach, Howard I.
    CURRENT DRUG DELIVERY, 2017, 14 (01) : 2 - 15
12